Washington: Ranbaxy Laboratories "systemically violated" good manufacturing practices, says the whisteblower whose alert led to a US probe, a day after India`s top drugmaker agreed to pay a hefty USD 500 million to settle charges over its adulterated drugs.
Azam Khan calls Modi a Fascist
Don`t rush with the Lokpal :BJP
CBI questions Madhu Koda on Coalgate
Stop govt from appointing new Army chief: BJP to Election Commission